You can buy the original Ibruxen 140 with delivery in Ukraine on our website. If you need help choosing a drug, contact our consultants. Before buying a remedy, get all the necessary prescriptions from an oncologist.

Composition and form of release of Ibruxen 140

The active component of Ibrutinib at a dosage of 140 mg is a low molecular weight inhibitor of Bruton’s tyrosine kinase, which, when it enters the gastrointestinal tract, is immediately absorbed and begins to inhibit metabolic processes in malignant cells. As a result of such an action, their growth and division stops. The malignant neoplasm gradually decreases in size. This allows you to speed up recovery and prevent the appearance of metastases.

The manufacturer of Ibruxen 140 is a large pharmaceutical company Everest (India). The drug is supplied to different countries, and Ukraine is no exception.

Ibruxen 140 is available in the form of capsules for oral administration. The original package contains 120 capsules.

Indications for use Ibruksen 140

Ibruxen 140 mg is prescribed for such diseases as:

• lymphocytic leukemia;
• Mantle cell lymphoma;
• Macroglobulinemia Waldenström.

The drug is used as a drug treatment if the patient has contraindications for chemotherapy and immunotherapy.

Contraindications to the use of Ibruxen 140

Ibruxen 140 contains the active substance Ibrutinib, which is contraindicated in:

• Acute and chronic renal failure;
• Cirrhosis, fatty hepatosis and other severe liver diseases;
• Taking certain medications, which include powerful inducers of CYP3A isoenzymes, fish oil, anticoagulants;
• Individual intolerance to the active substance;
• Pregnancy and breastfeeding.

This antitumor agent is not prescribed to persons under 18 years of age.

Possible adverse reactions Ibruksen 140

During treatment with Ibruxen 140, some patients may develop the following adverse reactions:

• Complex violations of the functioning of the gastrointestinal tract;
• Insomnia, anxiety, irritability, apathy;
• Allergy
• Violation of visual acuity;
• Joint pain;
• arrhythmia;
• Swelling of limbs and face.

With short-term mild adverse reactions, the treatment regimen does not change. If the patient’s health worsens, you should immediately contact your doctor.

Method of application and dosing regimen of Ibruxen 140

Ibruxen at a dosage of 140 mg is taken orally between meals at the same time, washing down the capsule with a sufficient amount of water. Daily dosage – 3 capsules. Capsules should not be broken and their contents dissolved in water. The state of health of the patient is monitored during the entire course of admission.

Method of application and dosing regimen of Ibruxen 140

Ibruxen is taken one capsule orally between meals at the same time. The daily dosage is 420 mg of Ibrutinib, or 3 capsules. If you miss one dose of the drug, do not double the dose for the next dose. During the entire course of treatment, the patient’s condition is monitored by an oncologist. The duration of therapy depends on the stage of cancer and related complications.

Application features of Ibruksen 140

Capsules are stored in their original packaging in a dry, dark place out of the reach of children and pets. After the expiration date, the drug must be disposed of.

The post Ibruxen 140 Mg (Ibrutinib) appeared first on BD Anticancer Drug Supplier.